Human TIMP-1 antibodies
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 15, 2006
Grant Date -
Jun 3, 2004
app pub date -
Apr 24, 2002
filing date -
Apr 24, 2001
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Human antibodies that bind to TIMP-1 can be used as reagents to diagnose and treat disorders in which TIMP-1 is elevated, such as liver fibrosis, alcoholic liver disease, cardiac fibrosis, acute coronary syndrome, lupus nephritis, glomerulosclerotic renal disease, benign prostate hypertrophy, colon cancer, lung cancer, and idiopathic pulmonary fibrosis.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully